Skip to search formSkip to main contentSkip to account menu

CAPOX Regimen

Known as: CAPEOX Regimen, Capecitabine-Oxaliplatin Regimen 
A regimen consisting of capecitabine and oxaliplatin used as a treatment for advanced stage colorectal cancer. This regimen differs from a similar… 
National Institutes of Health

Related topics

Related topics

3 relations
Colorectal Carcinomacapecitabineoxaliplatin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Prolonged Capecitabine Chemotherapy Following Capecitabine and Oxaliplatin (CAPOX) Regimen Chemotherapy Failed to Improve Survival of Stage III Colorectal Cancer After Radical Resection
Background Colorectal cancer (CRC) is considered to be a worldwide health problem because of its increasing incidence and… 
2018
2018
Phase II Randomized Trial of Biweekly Bevacizumab, Capecitabine, Oxaliplatin and Irinotecan (BEV- CAPEOXIRI) Versus Triweekly Bevacizumab, Capecitabine and Oxaliplatin (BEV- CAPEOX) in Metastatic…
AbstractBackground: Bevacizumab, Capecitabine and Oxaliplatin (BEV-CAPEOX) is an effective combination in patients with… 
2016
2016
Activity and tolerance of biweekly CapeOx-cetuximab in 1st line therapy of metastatic colorectal cancer (mCRC): Relation to K-ras mutation status.
e15018 Background: This novel q2w schedule trial combined oxaliplatin (Ox), flat dose capecitabine (Cape) and cetuximab(C) in… 
2008
2008
Modified CAPOX (Capecitabine plus Oxaliplatin) Regimen Every Two Weeks as Second-Line Treatment in Patients with Advanced Colorectal Cancer Previously Treated with Irinotecan-Based Frontline Therapy
Background: To evaluate the efficacy and tolerance of capecitabine (CAP) given every other week and biweekly oxaliplatin (OX… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)